NCT03016533: Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019 |
|
|
| Completed | 3 | 101 | US, RoW | Dolutegravir film-coated tablets, Dolutegravir film-coated dispersible tablets, ABC/DTG/3TC immediate release tablets, ABC/DTG/3TC film-coated dispersible tablets | ViiV Healthcare | HIV Infections | 12/24 | 12/24 | | |